LaMont BI - Search Results

1

Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.

Boger J, Payne LS, Perlow DS, Lohr NS, Poe M, Blaine EH, Ulm EH, Schorn TW, LaMont BI, Lin TY, et al. Boger J, et al. Among authors: lamont bi. J Med Chem. 1985 Dec;28(12):1779-90. doi: 10.1021/jm00150a007. J Med Chem. 1985. PMID: 3906131

2

Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency.

Bock MG, DiPardo RM, Evans BE, Freidinger RM, Rittle KE, Payne LS, Boger J, Whitter WL, LaMont BI, Ulm EH, et al. Bock MG, et al. Among authors: lamont bi. J Med Chem. 1988 Oct;31(10):1918-23. doi: 10.1021/jm00118a009. J Med Chem. 1988. PMID: 3050088

3

Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Boger J, Poe M, LaMont BI, Lynch RJ, Ulm EH, Vlasuk GP, et al. Bock MG, et al. Among authors: lamont bi. J Med Chem. 1987 Oct;30(10):1853-7. doi: 10.1021/jm00393a029. J Med Chem. 1987. PMID: 3309316

4

A uniquely potent renin inhibitor and its unanticipated plasma binding component.

Evans BE, Rittle KE, Bock MG, Bennett CD, DiPardo RM, Boger J, Poe M, Ulm EH, LaMont BI, Blaine EH, et al. Evans BE, et al. Among authors: lamont bi. J Med Chem. 1985 Dec;28(12):1755-6. doi: 10.1021/jm00150a001. J Med Chem. 1985. PMID: 3906130 No abstract available.

5

Novel renin inhibitors containing the amino acid statine.

Boger J, Lohr NS, Ulm EH, Poe M, Blaine EH, Fanelli GM, Lin TY, Payne LS, Schorn TW, LaMont BI, Vassil TC, Stabilito II, Veber DF, Rich DH, Bopari AS. Boger J, et al. Among authors: lamont bi. Nature. 1983 May 5-11;303(5912):81-4. doi: 10.1038/303081a0. Nature. 1983. PMID: 6341856

6

Renin inhibitors containing 2-substituted statine.

Veber DF, Bock MG, Brady SF, Ulm EH, Cochran DW, Smith GM, LaMont BI, Dipardo RM, Poe M, Freidinger RM, et al. Veber DF, et al. Among authors: lamont bi. Biochem Soc Trans. 1984 Dec;12(6):956-9. doi: 10.1042/bst0120956. Biochem Soc Trans. 1984. PMID: 6442237 No abstract available.

7

Design of proteolytically-stable, peptidal renin inhibitors and determination of their fate in vivo.

Boger J, Bennett CD, Payne LS, Ulm EH, Blaine EH, Homnick CF, Schorn TW, Lamont BI, Veber DF. Boger J, et al. Among authors: lamont bi. Regul Pept Suppl. 1985;4:8-13. doi: 10.1016/0167-0115(85)90210-1. Regul Pept Suppl. 1985. PMID: 3903877 No abstract available.

8

Benzolactams. A new class of converting enzyme inhibitors.

Parsons WH, Davidson JL, Taub D, Aster SD, Thorsett ED, Patchett AA, Ulm EH, Lamont BI. Parsons WH, et al. Among authors: lamont bi. Biochem Biophys Res Commun. 1983 Nov 30;117(1):108-13. doi: 10.1016/0006-291x(83)91547-4. Biochem Biophys Res Commun. 1983. PMID: 6318742

9

The intracellular metabolism of iodine in carcinogenesis.

Eskin BA, Sparks CE, Lamont BI. Eskin BA, et al. Among authors: lamont bi. Biol Trace Elem Res. 1979 Jun;1(2):101-17. doi: 10.1007/BF02821706. Biol Trace Elem Res. 1979. PMID: 24277065

10

The diagnostic and treatment approach to two common conditions by the physician members of a community health maintenance organization.

Bloom BS, Smith WP, Weitz D, Lamont B. Bloom BS, et al. Am J Manag Care. 1997 May;3(5):733-6. Am J Manag Care. 1997. PMID: 10169535 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters